We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current HYPE3 market cap is 18.94B. The company's latest EPS is BRL and P/E is N/A.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 2.03B | 2.65B | 2.58B | 2.3B | 2.21B |
| Operating Income | 535.8M | 734.13M | 735.84M | 512.03M | 579.4M |
| Net Income | 339.42M | 504.39M | 497.94M | 309.37M | 391.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 4.12B | 4.98B | 7.08B | 8.97B | 9.56B |
| Operating Income | 1.05B | 1.28B | 1.53B | 2.47B | 2.52B |
| Net Income | 1.16B | 1.3B | 1.33B | 1.7B | 1.65B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 0 | 0 | 0 | 0 | 0 |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 11.92B | 17.25B | 19.82B | 23.76B | 24.51B |
| Total Liabilities | 3.21B | 8.01B | 9.98B | 13.1B | 12.99B |
| Total Equity | 8.71B | 9.24B | 9.83B | 10.66B | 11.52B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 823.88M | 1.18B | 1.4B | 2.04B | 2.4B |
| Investing | -306.53M | -1.9B | -4.41B | -1.74B | -791.19M |
| Financing | 82.21M | 3.21B | 557.06M | 278.96M | -1.89B |
| Market Cap | 18.94B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 633.42M |
| Average Volume (1 week) | 2.79M |
| Average Volume (1 Month) | 2.96M |
| 52 Week Change | -27.32% |
| 52 Week High | 46.84 |
| 52 Week Low | 27.11 |
| Spread (Intraday) | 0.49 (1.63%) |
| Company Name | Hypera Pharma |
| Address |
rua nova cidade, 404 bairro, vila olimpia sao paulo, sao paulo 04547 070 |
| Website | https://www.hypermarcas.com.br |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
